The Newsroom

Investigations  /  01.11.2011

Attention CPEX Pharmaceuticals Shareholders: Acquisition of CPEX Pharmaceuticals, Inc. by FCB I Holdings Inc. Under Investigation

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) in connection with their efforts to sell the company to FCB I Holdings Inc., a newly formed company which is controlled by Footstar Corporation.  If the transaction is completed, CPEX shareholders will receive $27.25 in cash for each share of CPEX common stock they hold.  The transaction is expected to be completed in the second quarter of 2011.

Robbins Umeda LLP’s investigation concerns whether CPEX’s board undertook a fair process to obtain fair consideration for its shareholders.  Specifically, the investigation concerns whether members of CPEX board breached their fiduciary duties to its shareholders by failing to adequately shop the company before entering into the transaction with FCB.

If you are a shareholder of CPEX, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsarroyo.com.

Shareholder Information







Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.
I have read the disclaimer information.



Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns